Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
- PMID: 33887219
- PMCID: PMC8055494
- DOI: 10.1053/j.gastro.2021.04.025
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
Figures
Comment in
-
COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.Gastroenterology. 2022 Jan;162(1):349-350. doi: 10.1053/j.gastro.2021.05.030. Epub 2021 May 18. Gastroenterology. 2022. PMID: 34015337 Free PMC article. No abstract available.
References
-
- Wellens, et al. J Crohns Colitis. 2021 doi: 10.1093/ecco-jcc/jjab046. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
